Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Impact of α-Gene Deletions and β-Globin Cluster Haplotypes on Biological Parameters at Baseline and on Hydroxyurea in Children with Sickle Cell Anemia

Francoise Bernaudin, MD, Cécile Arnaud, MD, Annie Kamdem, MD, Serge Pissard, MD PhD, Isabelle Hau, MD, Ralph Epaud, MD PhD, Corinne Pondarré, MD PhD

Blood (2016) 128 (22): 10.

https://doi.org/10.1182/blood.V128.22.10.10

Published: 2016

Journal Articles

Inherited and Acquired Modifiers of Iron Status May Dramatically Affect the Phenotypic Expression of Dehydrated Hereditary Stomatocytosis

Corentin Orvain, Lydie Da Costa, MD PhD, Richard van Wijk, PhD, Serge Pissard, MD PhD, Veronique Picard, MD PhD, Lamisse Mansour-Hendili, PharmD, Muriel Giansily-Blaizot, MD PhD, Guillaume Cartron, MD PhD, Jean-Francois Schved, MD PhD, Patricia Aguilar-Martinez, MD PhD

Blood (2016) 128 (22): 1281.

https://doi.org/10.1182/blood.V128.22.1281.1281

Published: 2016

Journal Articles

Limits of Phenotype Analyses in the Diagnosis of HbS Heterozygosity. Example of a Hb S Carrier Phenocopy Due to Hb Arya (Alpha 1: codon 47 Asp>Asn) and a Gene Conversion

Serge Pissard, MD PhD, Adrien Pecriaux, Catherine Paillard, MD PhD, Anne Galoisy, PharmD, Jean Riou, Nathalie Le Metayer, Henri Wajcman, MD PhD

Blood (2016) 128 (22): 4850.

https://doi.org/10.1182/blood.V128.22.4850.4850

Published: 2016

Journal Articles

Chronic Hemolytic Anemia in Two Patients Double Heterozygotes for Pyruvate Kinase and Another RBC Glycolitic Pathway Deficiency.

Serge Pissard, MD, PhD, Nafa Saddedine, Aurelie Vasson, Marie-Odette Ballayguier, MD, Frederic Galacteros, MD, Henri Wajcman, MD, PhD

Blood (2006) 108 (11): 3721.

https://doi.org/10.1182/blood.V108.11.3721.3721

Published: 2006

Journal Articles

Evolution of Transfusion Requirement in Algerian Thalassemic Major (TM) and Intermediate (TI) Patients Treated with Hydroxyurea (HU).

Mohamed Bradai, MD, Serge Pissard, MD, Mohand Tayeb Abad, MD, Agnes Dechartres, MD, Jean-Antoine Ribeil, MD, Paul Landais, MD, Mariane De Montalembert, MD

Blood (2006) 108 (11): 1588.

https://doi.org/10.1182/blood.V108.11.1588.1588

Published: 2006

Journal Articles

Treatment with rhEPO Decreases the Need for Transfusion in Patients with βThalassemia.

Dora Bachir, MD, Anoosha Habibi, MD, Serge Pissard, MD, Zohra Ourabah, MD, Frederic Galacteros, MD-PhD

Blood (2004) 104 (11): 3778.

https://doi.org/10.1182/blood.V104.11.3778.3778

Published: 2004

NARROW

Impact of α-Gene Deletions and β-Globin Cluster Haplotypes on Biological Parameters at Baseline and on Hydroxyurea in Children with Sickle Cell Anemia

Inherited and Acquired Modifiers of Iron Status May Dramatically Affect the Phenotypic Expression of Dehydrated Hereditary Stomatocytosis

Limits of Phenotype Analyses in the Diagnosis of HbS Heterozygosity. Example of a Hb S Carrier Phenocopy Due to Hb Arya (Alpha 1: codon 47 Asp>Asn) and a Gene Conversion

Chronic Hemolytic Anemia in Two Patients Double Heterozygotes for Pyruvate Kinase and Another RBC Glycolitic Pathway Deficiency.

Evolution of Transfusion Requirement in Algerian Thalassemic Major (TM) and Intermediate (TI) Patients Treated with Hydroxyurea (HU).

Treatment with rhEPO Decreases the Need for Transfusion in Patients with βThalassemia.

Email alerts

ASH Publications

American Society of Hematology

Impact of α-Gene Deletions and β-Globin Cluster Haplotypes on Biological Parameters at Baseline and on Hydroxyurea in Children with Sickle Cell Anemia

Inherited and Acquired Modifiers of Iron Status May Dramatically Affect the Phenotypic Expression of Dehydrated Hereditary Stomatocytosis

Limits of Phenotype Analyses in the Diagnosis of HbS Heterozygosity. Example of a Hb S Carrier Phenocopy Due to Hb Arya (Alpha 1: codon 47 Asp>Asn) and a Gene Conversion

Chronic Hemolytic Anemia in Two Patients Double Heterozygotes for Pyruvate Kinase and Another RBC Glycolitic Pathway Deficiency.

Evolution of Transfusion Requirement in Algerian Thalassemic Major (TM) and Intermediate (TI) Patients Treated with Hydroxyurea (HU).

Treatment with rhEPO Decreases the Need for Transfusion in Patients with βThalassemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only